
The episode discusses the role of CELMoDs in innovative sequential care for patients with relapsed/refractory multiple myeloma.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/EXN865. CME/MOC/AAPA/IPCE credit will be available until June 29, 2027. The MoD Squad in Multiple Myeloma: CELMoDs as New Partners for Innovative Sequential Care in Relapsed/Refractory Disease In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and HealthTree Foundation for Multiple Myeloma. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Support This activity is supported through an educational grant from Bristol Myers Squibb. Disclosure information is available at the beginning of the video presentation.
Bristol Myers Squibb
Explore listener stats, chart rankings, contacts and more on the PeerView Oncology & Hematology CME/CNE/CPE Audio Podcast podcast page.